ProKidney completes Cayman-to-Delaware domestication effective July 1, 2025

PROKIDNEY CORP.

Each Cayman Class A and Class B ordinary share converted 1:1 into Delaware Class A or Class B common stock.
ProKidney Delaware issued amended tax receivable, lock-up, and exchange agreements on same terms as prior Cayman agreements.
Adopted new Certificate of Incorporation and Bylaws under DGCL; CUSIP changed to 74291D 104 as of July 2, 2025.
Class A common stock continues trading on Nasdaq under symbol PROK; no change in ticker or capital structure.
Restructuring includes subsidiary reorganization via ProKidney Holdings, LLC and ProKidney IPCo, LLC.

item 1.01item 3.03item 5.02item 5.03item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.